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Maturation and development of mammalian hematopoietic cells are influenced by 
a  variety of chemicals and  physiological mediators. These  influences can  be studied 
by culturing immature  hematopoietic cells in  vitro and  observing the  induction  of 
mature cellular characteristics. Culture medium conditioned with activated lympho- 
cytes, prepared by incubating lymphocytes with  mitogen or altogeneic antigens, has 
been  analyzed  as  a  source  of  lymphocyte  mediators  for  cell  differentiation.  This 
conditioned medium  induced the development of normal mouse prothymocytes into 
mature T  cells (1), human  B  lymphocytes into plasma cells (2),  and  maturation  of 
erythrocytes  (5).  It  also  has  activity  for  induction  of differentiation  of malignant 
hematopoietic cells. Fu et  al.  (3-4)  showed T  lymphocyte-mediated development of 
plasma cells from B lymphocytes from chronic lymphocytic leukemia (CLL) 1 patients, 
and  Chiao  et  al.  (6)  showed  the  development  of pre-T  tymphocytes  from  acute 
lymphocytic leukemia (ALL) patients into mature T  cells. We recently demonstrated 
that  activated  T  lymphocyte-conditioned  medium  can  induce  maturation  of  the 
human promyelocytic leukemic HL-60 cell line along the monocytic cell pathway (7). 
We  now  report  that  supplementation  with  lymphocyte-conditioned  medium  can 
induce  terminal  maturation  of aneuploid  leukemic  cells  from  patients  with  acute 
myelogenous  leukemia.  Cell  cycle  analysis  has  demonstrated  the  relationship  of 
cellular proliferation to induced cellular maturation. 
Materials  and  Methods 
Patient Identification.  Patient R.I., a  21-yr-old male, had acute myelogenous leukemia. The 
leukocyte count  was  10,900/ram3;  hemoglobin,  11.9 g/deciliter; and  platelets, 47,000/mm 3. 
There were 60%  monoblasts, 6%  myelocytes, 5% metamyelocytes, 26%  lymphocytes, and  3% 
monocytes, and a bone marrow examination was consistent with a diagnosis of M5B according 
to French, American, British  (FAB) classification. He received daunorubicin, cytosine arabi- 
noside, and thioguanine, without  achieving a  remission, failed to respond to further chemo- 
therapy, and died 6 mo later. 
Patient A.N. was a  20-yr-old female, who presented with a  platelet count of 40,000/ram 3, 
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and  she  was  treated  with  prednisone for  presumed  idiopathic thrombocytopenic purpura, 
without response.  Subsequently, a bone marrow aspiration established the diagnosis of acute 
nonlymphocytic leukemia  (M2).  The  leukocyte  differential  count  included  1~  nucleated 
erythrocytes, 71% blasts, 10% neutrophils, 1% bands, 15% lymphocytes, and 2% monocytes. She 
was treated with adriamycin and cytosine arabinoside and then daunorubicin in combination 
with cytosine arabinoside and thioguanine, and achieved remission 6 mo later. She  relapsed 
after 3 too, failed further therapy, and died 3 mo later. 
Patient M.B.  was  a  75-yr-old  male who presented with a  leukocyte count of 5,000/mma; 
hemoglobin,  10.6 g/deciliter;  and  platelets,  55,000/mm  3.  A  bone  marrow  aspiration  was 
hypercellular, with 10% erythroid precursors,  15% blasts, 23% promyelocytes, 18% myelocytes, 
17% polymorphonuclear leukocytes,  16% monocytes, and  1% lymphocytes, consistent with an 
accelerated phase of chronic myelogenous leukemia. Cytogenic study revealed normal karyotype 
without evidence of the Philadelphia chromosome. His leukocyte count subsequently rose to 
>400,000, with 1% nucleated erythrocytes, 66% blasts, 10% promyelocytes, 4% myelocytes, 8% 
bands, 1% eosinophils, and 10% neutrophils. The morphology according to FAB was M2. The 
patient was  treated with a continuous infusion of cytosine arabinoside without response.  He 
developed pulmonary insufficiency, renal failure, and died 1 mo later. 
Membrane Marker Determinations.  Spontaneous rosetting of T  lymphocytes with sheep eryth- 
rocytes  (SRBC) and detection of surface membrane immunoglobulins  by immunofluorescence 
using rabbit IgG-F(ab')2 reagent were performed as described (6, 8). Membrane receptors for 
complement components were detected by a rosette method, using indicator erythrocytes coated 
with rabbit IgM antibodies and sensitized with mouse serum as a source of complement (6). 
Phagocytosis was studied by incubating cells with 0.8-/Lm latex particles (7). Cells engulfing 
many particles were scored as positive. 
Isolation of  Immature Leukemic Cells.  Peripheral blood or bone marrow leukocytes were isolated 
from heparinized samples from leukemic patients by Ficoll-Hypaque gradient centrifugation 
(9).  Immature  cell-enriched preparations  were  obtained  by  first  removing adherent  and 
phagocytic cells using the carbonyl iron method (10). Cells bearing receptors for complement 
or IgG and T cells were removed by centrifugation after the formation of respective rosettes  (6). 
Cells attached to the plastic or glass surface after vigorous pipetting were reported as adherent 
cells. To collect adherent cells, cold 1  × trypsin-EDTA (Flow Laboratories, Inc., Rockville, MD) 
was added to flasks and incubated at 4°C for 3-30 min. Cells were collected after pipetting and 
washed with 20% fetal calf serum (FCS) supplemented RPMI 1640 medium. 
Leukemic Cell Cultrues and Conditioned Media.  Immature cell  preparations were cultured at 
0.25-0.5 ×  106 cells/ml in RPMI  1640 medium supplemented with 2 mM of glutamine, 1% 
antibiotics, and 15% heated FCS. Lymphocyte conditioned medium (CM) or control medium 
was added at a final concentration of 30%. CM was prepared from normal human peripheral 
blood lymphocytes (PBL)  using the method described elsewhere  (6,  7).  PBL  from  multiple 
donors were cultured at  1 ×  106 cells/ml in RPMI 1640 medium with 1% phytohemagglutinin 
M  (PHA)  (Gibco,  Grand Island Biological  Co.,  Grand Island, NY)and  1-5%  autologous 
plasma. The culture supernatants from  3-d  cultures were  used as  unseparated lymphocyte- 
conditioned medium. Control medium was prepared by adding 1% PHA to PBL from a single 
donor that had already been incubated for 3 d. 
The cultures were maintained at 37°C in a 5% CO2 humidified atmosphere, and the medium 
was changed every 2  4 d after the initiation of cultures. Cell viability was determined by the 
trypan blue exclusion method. To test cell markers and functions, cultured cells were washed 
with 4°C RPMI  1640 medium, incubated in RPMI  1640 at 37°C for  1 h, and washed again 
with 37°C RPMI 1640. To determine the cell type providing the activity in unseparated CM, 
CM were also prepared from isolated SRBC rosetting T  lymphocytes, T  lymphocyte-depleted 
PBL preparations, and monocyte-depleted PBL preparations. Monocytes were removed by the 
carbonyl iron method (10). Myeloperoxidase staining (7) showed  that these  preparations and 
the T  lymphocyte preparations had <0.1% monocytes. Each CM was prepared using the same 
culture conditions described for unseparated CM. 
Cell Morphology.  Smears  of cultured  lymphocytes were  made  using a  Shandon  Elliott 
cytospin centrifuge (Shandon Southern Instruments Inc., Sewickley, PA). Cell morphology was 
examined with May-Grunwald Giemsa stain. Staining for nonspecific esterase  using c~-napthyl J.  w.  CHIAO,  M.  ANDREEFF, W.  B.  FREITAG, AND Z. ARLIN  1359 
acetate or naphthol ASD chloroacetate was carried out according to the method of Yam et al. 
(12). Morphology of adherent cells was examined after their adherence to a cover glass placed 
in the culture containers. 
Flow  Cytomeoy of DNA and RNA.  The cells were stained for DNA and RNA with acridine 
orange according to the method described by Darzynkiewicz et al. (13) and Traganos et al. 
(14). This staining procedure has been shown to be stoichiometric for DNA and RNA (15). 
Double-stranded RNA  is denatured in the presence of EDTA.  Native double helical DNA 
intercalates the dye and fluoresces  orthochromatically green.  Single-stranded RNA forms  a 
different complex with acridine orange and fluoresces red (16). The DNA and RNA measure- 
ments permit identification of live and dead cells, and the number of cells in G0/h S, and G2M 
phases of cell cycle. The RNA content of cells in G0/t is expressed  as RNA index (RI), which is 
the mean RNA content of G0/t cells  of the sample times  10,  divided by the median RNA 
content of control Go human lymphocytes (15). To determine DNA stemlines, the ratio of DNA 
G0/~ leukemic cells to DNA of Go normal lymphocytes used as a control is calculated. 
A computer-interfaced research cytofluorograph (model FC 200; Ortho Instruments, West- 
wood, MA)  was  used to obtain simultaneous measurements of the fluoresence of individual 
cells in two separate wavelength bands (Fsa0, in a band of 515-575 nm; and F~0, in a  band 
from 600-650 nm) (15). Green pulse-width, i.e., the time the nucleus took to pass through the 
illuminating  beam, was also recorded and used to distinguish single cells from cell doublets and 
other cell aggregates  (15). The three cell features were  measured per sample and stored  as 
correlated measurements in a Nova 1220 minicomputer (Data General, Southwood, MA) and 
on magnetic disks.  Data analysis was  performed with a  Tektronix 4010-1  graphic terminal 
(Tektronix, Beaverton, OR) using computer programs developed by T. Sharpless (16). 
Autoradiography.  Cell labeling  and autoradiography were performed according to the method 
of Nishikori et al. (17). Cells in FCS-supplemented medium were labeled with t Ci/ml tritiated 
thymidine (15 Ci/mM, New England Nuclear, Boston, MA) at 37°C for  1 h. Autoradiographs 
were  developed  from  cytocentrifuge-prepared slides  using Kodak  NTB emulsion (Eastman 
Kodak Co., Rochester, NY) and a 7-d exposure time. 
Results 
CM-induced  Development  of Adherent  Cells.  Table  I  shows  that  the  isolated  cell 
preparations  from  leukemic  patients  lacked  SRBC  rosetting  capacity,  membrane 
immunoglobulins, IgG  or  complement  receptors,  and  phagocytic  capacity.  These 
preparations were enriched with blasts and promyelocytes. Adherent cells developed 
2-24 h  after incubation with CM  and were one of the earliest  indications of CM- 
induced maturation. Cultures with control medium or lacking CM showed either very 
few or no adherent cells. The majority of these adherent cells were macrophage-like 
TABLE  I 
Membrane Markers and Characteristics of lsolated Immature Cells frorn Myelogenous Leukemia Patients 
Membrane  markers and characteristics  (+7,) 
Mcm- 
FAB mot-  Cell source  Cell  prepara-  Blast  Adherent  Patient  l)iagnosis  phologv  tion  SRB( /  lgG re-  Comple-  brane  Phagu- 
•  '  merit re-  inlnlu+  cytic 
rosette  ccptotzs  cells 
ceptors  liOn]o-  cells 
bins 
M  B.  Myeloprolifi:rat iv+  M2  Marrow  Unsepat ated  2ti  3  1  23  I  10  P resev+t 
disorder  with  a  lsolatcd  62  0  7  0  0  0  Absent 
blast  crisi~ 
A.N.  AML  M2  Blood  Unseparated  62  1.5  I  1{)5  0.2  10  Present 
Isolated  85  0  4  0  0  0  Ahsent 
RI.  ANNL  MSB  Mat row  Unseparated  65  7  0  8  1  11  Present 
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TABLE II 
CM-induced Development of Adherent Macrophage-like Cells and Their Properties 
Patient 
Differential counts of adherent cells  Cellular markers 
Culture  Macro-  Comple- 
Promye-  Mono-  phage-  men( re-  Phago- 
period  Blast  locyte  cyte-like  like  cepmrs  cytic cells 
d  °4  5i 
M.B.  2  2  t 2  0  86  38  40 
5  0  3  l0  87  58  62 
A.N.  1  3  15  15  67  42  45 
5  0  5  l0  85  48  48 
R.I.  2  4  6  8  82  40  65 
4  0  2  5  93  62  78 
TABLE III 
Differential Count Analysz) and the Detection of Monocytes and Macrophage-like Cells in Culture Suspensions of 
CM-supplemented Cultures of Leukemic Cells 
(lOml)IC- 
Maclo-  lll('lll  lu- 
Patient  Q;ultut t'  Ptomyc-  Myelo-  (bamdu-  I,~,  mpho-  Morn)  Pha~o 
phage-  t cptot  ¢~ti( cells  and  FAB  period  Cltlttlle condition  Blast  k)cytc  %~te  c',tc  c~,tc  %to-like  like  bcatint~ 
ccll~ 
d 
MB,  (I  (Bclbre culture)  62  30  5 
(M2)  I  +CM  6O  38  I) 
+(',urn m]  medJmn  53  3!)  I) 
2  +CM  27  44  I) 
+Conuul  nlcdiunl  58  3~1  0 
4  +CM  14  30  (I 
+Control  medium  50  39  4 
AN  0  (Bc/'ot c  cullu~c)  98  2  0 
(M2)  2  +CM  48  39  0 
+Con H'o]  nlcdiuvll  45  51l  3 
4  +CM  0  q)  l) 
+Control  nlcdium  I0  18  2 
R  L  0  (l'~cfore culture)  g!)  l  0 
(M5B)  2  +(:M  65  15  0 
+(~untto]  medium  711  18  (F 
4  +CM  2  IJ  0 
-I-Contt ol  medium  43  45  0 
I  0  (]  I) 
0  1 
II  0 
7  22  2O  22 
0  I  ~l  1 
I I  I ')  dJ  28 
[1  (I  0  ~1 
[)  0  (I  J~ 
I)  13  II  III 
II  0  l  I 
44  56  13  fi~ 
4  'I  ]  I 
o  o  ()  (J 
3  15  I)  (I 
(]  o  (I  o 
(I  5  1  (I 
after 5 d in culture (Table II). They were positive for a-napthyl esterase and negative 
for  naphthol  ASD  chloroacetate  stains,  indicating  that  they  were  monocytic  cells. 
Table II also shows that cells with membrane complement receptors and phagocytic 
capacity  were  detected  among  the  adherent  cells.  The  sum  of the  percentages  of 
macrophage-like  cells  and  cells  bearing  complement  receptors  exceeded  I00%,  sug- 
gesting that macrophage-like cells possessed the receptors. By the same analysis, it can 
be seen that these cells also had phagocytic capacity. 
Changes in Cell Morphology  and Function in Culture Suspensions.  Cells in culture suspen- 
sions  underwent  morphological  changes,  and  some  cell  aggregates  were  detected. 
Table  III  shows 29%, 13%, and  18%  of the cells  in CM  cultures  of M.B.,  A.N., and 
R.I. were monocyte- and macrophage-like after 2 d, compared with 0% in the control 
cultures  and  initial  culture  preparations.  As  the  proportion of monocyte- and  mac- 
rophage-like cells  increased  with  time,  the  proportion  of immature  cells  decreased. J.  W.  CHIAO, M.  ANDREEFF, W.  B.  FREITAG, AND Z.  ARLIN 
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Fxo.  1.  Increase of absolute number of macrophage-like cells in CM-supplemented cultures of 
leukemic cells of patients M.B., R.I., and A.N. •  indicates the number of macrophage-like cells per 
ml in CM-supplemented cultures; C) indicates the number of macrophage-like  ceils per ml in control 
cultures lacking CM; A indicates the number of macrophage-like cells per ml in cultures supple- 
mented with a control medium prepared by adding 1% PHA to PBL from a single donor that had 
been incubated for 3 d. 
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CM cultures of A.N. and R.I., which initially had 98% and 89% blasts, had 0% and 
2% of these cells  and  100% and 98% of mature cells by day 4. 
Control  cultures  of M.B.,  A.N.,  and  R.I.  were  terminated  on  days 8,  6,  and  5, 
because  of cell  death.  The  CM-supplemented  M.B.,  A.N.,  and  R.I.  cultures  were 
maintained for 35, 9, and  11 d. 
The absolute number of monocyte- and macrophage-like cells  was determined by 
multiplying cell type proportions by cell number per unit volume. Fig.  1 depicts the 
increase in absolute number of macrophage-like cells  in CM cultures of M.B., A.N., 
and R.I. from initiation of the cultures to the first  medium change. The number of 
macrophage-like cells  increased from 0 to ~2.7  ×  105 cells/m] in the CM culture of 
M.B. by day 3. No macrophage-like cells were detected in control cultures. The total 
viable cell  number in CM cultures increased from 0.5 X  106 cells/ml on day  1 to  1.2 
X  106 cells/ml on day 4. In cultures lacking CM, the cell  number increased from 0.5 
X  106 ceUs/ml on day  1 to  1.1  ×  106 on day 3, and decreased to 0.8 ×  106 on day 4. 
Fig.  1 shows that the increase of macrophage-like cells  was similar in A.N. and R.I. 
cultures.  The development of mature cells  and  increase  in  number of these cells  in 
CM cultures strongly indicates lymphocyte CM-induced development from immature 
cells. 
The  development  of monocyte- and  macrophage-like cells  in  CM  cultures  was 
coupled with reactivity with a-napthy] acetate, which is characteristic of monocytic 
cells, and a decrease in the number of cells with the myeloid esterase marker, naphthol 
ASD chloroacetate. In contrast, the number of cells with myeioid markers in control 
cultures remained high. These observations suggest that CM induces cellular devel- 
opment along the monocytic cell pathway. 
The  proportion of cells  with  complement  receptors  and  phagocytic capacity in- 
creased in CM cultures. Approximately 25%, 43%, and 35% of the cells in M.B., A.N., 
and  R.I. cultures showed complement receptors by day 4  (Table III). Complement 
receptor cells, detected around day 2 to 3, appeared later than adherent cells. Smears 
of cells rosetting with complement receptor indicator erythrocytes were prepared.  It 
was  determined  that  they were  monocyte- or macrophage-like cells.  Table  III also 1362  INDUCED  DIFFERENTIATION  OF  ANEUPLOID  LEUKEMIC  CELLS 
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Fro.  2.  DNA-RNA histograms of flow cytometric measurements of leukemic cells of patient M.B. 
after 2 d  in culture. Frame B shows CM cultures had a  higher proportion  of cells in S phase than 
did cultures supplemented with control  medium in frame A. Most of the adherent cells obtained 
from CM cultures (frame C) had low RNA content, and the proportion of these cells with low RNA 
was greater than that of the cells in culture suspensions (frame B)  or the cells supplemented with 
control medium (frame A). These measurements show that the adherent cell population in frame C 
had the lowest proportion of S phase cells. 
TABLE  IV 
Flow Cytometric Measurement of Aneuploid DNA Content, Reduced RNA  Content, and Cell Cycle Phases 
of CM-induced Mature Cells 
Culture  RNA in-  DNA 
Patient  Culture condition  dex 
period  (R.I.)  content 
Cell cycle phases 




(Marrow biopsy)  17.3  2.4  76 
With CM  24.9  2.4  59 
With control medium  18.1  2.4  75 
Adherent cells  12.8  2.4  82 
With CM  9.9  2.4  69 
With control medium  22.5  2.4  86 
(Marrow biopsy)  21.3  2.2  91 
With CM  13.5  2.2  78 
With control medium  18.7  2.2  92 
With CM  13.5  2.2  84 
With control medium  (Cells had died) 
19  5 
31  10 
18  7 
9  9 
24  7 
I 1  3 
8  1 
16  6 
5  3 
10  6 
shows  that  28%,  68%,  and  60%  of  the  cells  in  M.B.,  A.N., 
phagocytic  by  day  4.  No  increase  of complement  receptors 
seen  in  cultures  with  control  medium  or lacking  CM. 
and  R.I.  cultures  were 
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Reduction of RNA Content and Aneuploid DNA Content.  Flow cytometric measurement 
of  cells  during  the  maturation  induction  period  showed  an  appearance  of  cell 
populations having lower cellular RNA content  than the cells not treated with CM. 
Early changes in RNA content in M.B. cells are shown in the histogram of Fig. 2, and 
quantitative data are presented in Table IV. After 2 d  in culture, cell suspensions of 
CM  cultures  had  a  higher  proportion of cells with  higher  RNA content  (R.I. 24.9, 
Table IV) than was found in cultures lacking CM (R.I.  18.1).  This might be because 
of the presence in the CM cultures of a  higher proportion of proliferating immature 
cells  in  S  phase  (31%)  than  in  cultures  lacking  CM  (18%).  Adherent  cells  in  CM 
cultures had a significantly lower RNA content (R.I. 12.8) than did the cells in culture 
suspensions  (R.I. 24.9).  Approximately 75% of the G0/a adherent cells had low RNA 
content. Because the sum of the proportion of low RNA adherent cells (75%)  and the 
proportion  of adherent  cells with  macrophage-like morphology (86%,  Table I) was 
>100%,  this  would  indicate  that  the  macrophage-like cells  had  low  RNA  content. 
These adherent cell populations showed cells in the cell cycle, as indicated by cells in 
S and G2M with a low RNA content, fulfilling the criteria for viable cells because the 
cells maintained  their capacity to be stained with acridine orange.  Dead and dying 
cells regularly lose DNA or the capacity of the DNA to be stained, which  results in 
lower green fluorescence. 
Analysis of fresh and  cultured  cells by flow cytometry from patients  M.B.,  A.N., 
and R.I. revealed hyperdiploid DNA stemlines. Fig. 3 shows that the majority of M.B. 
cells had  2.4  DNA content  (C).  Most of these cells had a  large G0/x RNA content. 
Similar  analysis  revealed  that  almost  all  cells  from  R.I.  and  A.N.  were  2.2  C 
hyperdiploid.  Cultured  cells  from  these  leukemic  patients  were  also  measured  for 
DNA content. Table IV shows that  the same hyperdiploid stemline was detected in 
these cells as was seen in the fresh patient cells. Table IV shows further that almost all 
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Fro.  3.  Scatterplot  of simultaneous flow cytometric measurements of DNA  and  RNA showing 
hyperdiploid  DNA content of patient mononuclear cells before culturing. Cells with diploid DNA 
content (2.0 C) proliferating from G0/1 to S and G2M phases of the cell cyle are shown on the left 
side of the plot. Almost all MB cells were found in the 2.4 C hyperdiploid position and most of them 
were in C,0/1 phase with high RNA content. These aneuploid cells in G0/], S, and G2M are shown on 
the right  side of the plot,  separated  from  the diploid  cells by an  oblique  line.  Each dot  on  the 
scatterplot represents the electronic signal of the red RNA and green DNA fluorescence of a  single 
cell passing through the laser beam during measurement. The details of the DNA and RNA staining 
and fluorescence are described in the Materials and Methods section. 1364  INDUCED  DIFFERENTIATION  OF  ANEUPLOID  LEUKEMIC CELI,S 
TABLE  V 
Inductive Activity for the Maturation of Leukemia Cells Using CM Prepared  from  T Lymphocytes 
PHA-stim-  PHA-stim-  PHA-stim- 
ulated al-  PttA-stim-  ulated al-  u[ated  al- 
logeneic  ulated al-  logeneic  logeneic 
lympho-  logeneic T  lympho-  non-T 
cytes  lympho-  cyte prep-  lympho- 
(unsepara-  cytes  arations of  cyte prep- 














Day 2, R.I. culture 
Adherent cells  +  +  +  - 
Morphology (%) 
Blast and promyelocyte  80  85  83  90 
Monocyte and macrophage-like  18  12  14  0 




Day 4, R.I. culture 
Adherent cells  +  +  +  - 
Morphology (%) 
Blast and promyelocyte  2  15  15  85 
Monocyte and maerophage-like  98  85  85  2 
Intermediate*  0  0  0  13 





Day 4, M.B. culture  +  +  +  -  - 
Adherent cells 
Morphology (%) 
Blast and promyelocyte  74  63  66  93  89 
Monocyte and macrophage-like  26  33  34  3  0 
Intermediate*  0  4  0  4  11 
Complement receptors  (%)  25  28  28  1  0 
Day 6, M.B. culture 
Adherent cells  +  +  +  -  - 
Morphology (%) 
Blast and promyelocyte  70  75  74  94  94 
Monocyte and macrophage-like  30  25  26  2  0 
Intermediate*  0  0  0  4  6 
Complement receptors  27  20  19  0  0 
* Mixture of myelocytes, granulocytes,  and lymphocytes. 
entiated  cells.  Because  morphological  and  marker  analysis  of these  adherent  cells 
showed that  -86%  of the cells were macrophage-like, this would indicate that  these 
macrophage-like cells were hyperdiploid. A  similar conclusion could be derived from 
the analysis of R.I. and A.N. cells. Nearly all of these cells cultured with CM  for 4-5 
d  maintained  their 2.2 C  DNA  stemline, while morphologically they were monocyte- 
and macrophage-like and acquired mature characteristics. These results indicate that 
CM-induced  maturation  of leukemic  cells  to  monocyte- and  macrophage-like cells 
may be independent of the DNA  abnormality. j.  w. CttlAO,  M.  ANDREEFF, W.  B.  FREITAG, AND Z.  ARLIN  1365 
Cellular Proliferation.  Cultures supplemented with CM showed a  larger proportion 
of proliferating cells than cultures lacking CM. Table IV depicts CM-stimulated cell 
proliferation as shown by cell cycle phases. 2-d M.B. cultures supplemented with CM 
had  31%  cells  in  the  replicating  S  phase,  an  increase  from  19%  in  the  initial 
preparations.  This  indicates  that  the  stimulatory  activity  for proliferation  was  not 
due to the presence of PHA, but was most likely attributable to activated lymphocyte 
products.  On day 6, the proportion of cells in S phase in CM cultures was 24% and 
remained higher than the control  cultures.  A  decrease of cells in  S phase in control 
cultures was reflected in a  steady decline  in cell viability and cell counts beginning 
from day 3, resulting in their termination by day 8. CM cultures had a cell viability 
>94% and were continued  for 35 d. At this point, almost all cells were macrophage- 
like,  and  cell  proliferation  had  ceased.  During  the  culture  period,  adherent  cells 
developed  continuously.  This  was  shown  by  removing  cells  in  suspensions  and 
transferring  them  to  a  new  flask.  Development  of macrophage-like adherent  cells 
always ensued.  From days 7 to 20, ~24% of the cells were in S phase, while ~20% of 
the cells in culture suspensions were monocyte- and macrophage-like, and 80% were 
blast and promyelocyte-like cells. Analysis of autoradiographs of cellular incorporation 
of [3H]thymidine after 12 d  in culture showed ~20% radiolabeled blast-like cells and 
no  labeled  macrophage-like  cells,  excluding  proliferation  as  their  source.  These 
observations indicate that CM supports proliferation of the immature cells, and the 
differentiated mature cells developed after cessation of cell replication.  Proliferation 
and maturation of immature cells were concurrent events in the CM cultures. 
From  days  20  to  30,  proportions  of blasts  and  promyelocytes decreased,  while 
monocyte- and macrophage-like cells increased,  leading to a  predominance of mac- 
rophage-like cells. Cell counts and viability decreased, and cell proliferation ceased. 
CM-induced proliferation was also seen in A.N. and R.I. cultures (Table V). 
T  Lymphocytes as Source of Maturation  Inducer.  To determine the cell types involved 
in  producing  the  maturation  activity in  unseparated  CM, conditioned  media from 
different  cell  types were prepared.  The CM  were tested with  leukemic cells for the 
development  of adherent  cells,  morphological  changes,  and  increase  in  cells  with 
complement receptors. Table V shows that, whereas T lymphocyte CM and monocyte- 
depleted lymphocyte CM induced maturation, non-T lymphocyte CM and CM from 
unstimulated lymphocytes did not. These results suggest that T  lymphocytes are the 
cell type most responsible for production of the maturation activity in CM and that 
the inducer stems from activated T  lymphocytes. 
Discussion 
In this paper, we report induced  proliferation and maturation  by an activated T 
lymphocyte  product  in  primary  cultures  of  human  leukemic  cells.  We  cultured 
immature leukemic cells isolated from patient leukocyte preparations after the deple- 
tion of cells showing mature cellular functions and membrane characteristics. The use 
of these immature cells provided a distinct advantage because the presence of mature 
cells in culture could be attributed to induction. 
The development of mature cells as a  result of induced  maturation was shown by 
multiple criteria. These included development of adherent cells with macrophage-like 
morphology.  These  cells  as  well  as  the  morphologically  mature  monocytes  and 
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complement  receptors,  phagocytic capacity, and  reactivity with  a-napthyl  acetate. 
Quantitation  of cellular  RNA  content  showed  that  mature  cells  with  low  RNA 
content developed during the induction period, correlating with other criteria. There 
was an increase in the proportion as well as number of monocyte- and macrophage- 
like cells. With the evidence showing that the macrophage-like cells did not proliferate, 
our observations would indicate induced differentiation leading to the development 
of  mature  cells.  A  number  of  recent  papers  have  reported  the  development  of 
macrophages from cells from leukemic patients after in vitro incubation with phorbol 
esters  (18-20). Our observations of the properties of the macrophage-like cells  are in 
line with the characteristics of macrophages described in these reports. 
Cellular  RNA content  was quantitated  in  this  study by precise  measurement  of 
RNA in individual cells.  Andreeff et al.  (15) showed that immature cells  from AML 
patients had high RNA content, whereas maturing cells  from CML patients had low 
RNA content. Our recent report (7) showed that macrophages had low RNA content 
when they were induced to differentiate from the leukemic HL-60 cell  line that had 
high  RNA content.  In  the  present  study,  cells  with  decreased  RNA content  were 
found in  CM-induced cultures.  These cells  were  most  evident  among the  adherent 
cells with macrophage-like morphology and acquired characteristics of mature cells. 
In all three patients, hyperdiploid DNA stemlines were found in all cells throughout 
the culture period by DNA-RNA flow cytometry. It was found that macrophage-like 
cells with mature functional and marker features had the same aneuploid stemline as 
the  undifferentiated  cells.  This  is  crucial  evidence  for  the  leukemic  origin  of the 
differentiated cells and excludes the origin of differentiated cells  from normal cells in 
the cultures. These analyses indicate that leukemic cells can be induced to differentiate 
to mature cells, and the in vitro induced maturation may be independent of the DNA 
abnormality. Evidence showing that differentiated cells share the same genetic defect 
as the undifferentiated  leukemic cells  has not been well established.  Descriptions of 
aneuploid leukemic cell differentiation have mainly derived from work with cell lines 
or from chromosomal defects detected in the undifferentiated cells  (3, 4, 7, 21). 
Because a higher rate of proliferation was found in CM-supplemented cultures than 
in  those  lacking CM,  interaction  of CM  with  the  cells  must  have  resulted  in  the 
stimulation of some cells  from the resting phase into the replicating phase. The long- 
lived cultures of patient M.B. provided an opportunity for analysis of the relationship 
of cell replication to differentiation.  From the onset of induction, there was simulta- 
neous  proliferation  of immature  ceils  and  development of mature  cells.  These  two 
events  must  be  intertwined.  At  the  outset  of the  culture  period,  there  were  more 
immature  cells  than  mature  cells.  Mature  cells  later  became  predominant  as  the 
proliferating population of immature cells  was reduced.  This indicated a  shift  from 
an initial state of simultaneous replication and differentiation to a state characterized 
mainly by differentiation leading to termination of the cultures.  A difference in the 
balance between proliferation and differentiation might help to explain why the M.B. 
cultures lasted longer than the other cultures. The other cultures were found to have 
fewer proliferating S phase cells  (16%, Table V) than M.B. cultures (31%), and their 
proliferation also ended earlier.  The continuous development of mature cells  seen in 
M.B. cultures would suggest that proliferation may precede cellular maturation that 
takes  place  after  cell  replication  has  ceased.  This  is  in  accordance with  the  recent 
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proliferation was shown to precede differentiation, and interaction between CM and 
cells resulted  in  suppression  of DNA  replication  before the  cells expressed mature 
functional markers (7). 
Estimates made using culture suspensions would indicate ~ 15-30% of the leukemic 
cells became mature after 2 d in culture. The actual proportions of mature cells might 
be higher because there was continuous development of an adherent cell population 
comprised  mainly  of  maturing  cells.  However,  this  may  not  necessarily  indicate 
maturation  of every immature cell.  Weinberg's recent  observations  (22)  of phorbol 
ester-induced  maturation of HL-60 leukemic cells showed  that  the induced  macro- 
phage-like cells were capable of killing the undifferentiated parent HL-60 cells. This 
would  indicate that  the process of differentiation  and  the capacity of the maturing 
cells to eliminate tumor cells may both control the undifferentiated cell population. 
It is likely that the differentiation process precedes and initiates the cytotoxic process. 
Whether  the  induced  macrophage-like cells  in our studies  of patient  leukemic cells 
may have the  capacity  to  control  the  growth  of undifferentiated  cells  is  currently 
being studied in our laboratory. 
Summary 
Human leukemic cells were induced to proliferate and mature to macrophage-like 
cells in primary cultures supplemented with conditioned medium (CM)  from phyto- 
hemaggglutinin  and  alloantigen-stimulated  normal  T  lymphocytes. Blast  and  pro- 
myelocyte-enriched preparations, isolated after depletion of adherent phagocytic cells 
and lymphoid cells from samples of myelogenous leukemia patients, were suspended 
in  liquid  cultures with  30%  CM.  Cell cycle analysis was performed throughout  the 
course of induced  cellular maturation.  Within  24  h  of exposure  to CM,  cells with 
macrophage-like morphology were  identified  among the  developing adherent  cells. 
Approximately 15-30% of the cells in culture suspensions also developed macrophage- 
like morphology and esterase reactivity with a-napthyl acetate after incubation for 2 
d. The number of these nonproliferating cells increased and became predominant in 
the later culture period. Flow cytometric measurement of DNA content showed that 
these mature cells had the same aneuploid stemline as the undifferentiated leukemic 
cells, indicating that genetically abnormal leukemic cells can be induced to differen- 
tiate.  Reduction  in  the  total  RNA  content  of the  macrophage-like cells  was  also 
determined by flow cytometry. Reduction in RNA and development of adherent cells 
served as early markers of maturation, in addition to the later acquisition of comple- 
ment receptors and phagocytic capacity. Cell cycle analysis showed that CM stimu- 
lated  the  proliferation  of  immature  cells.  This  initial  proliferation  may  precede 
intertwined  events  of proliferation  and  concurrent  maturation  of immature  cells. 
Later in the culture period, cellular proliferation decreased, leading to termination of 
the cultures. 
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